Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
45,101,565
-
Total 13F shares
-
22,809,127
-
Share change
-
+753,680
-
Total reported value
-
$1,129,308,254
-
Price per share
-
$49.51
-
Number of holders
-
115
-
Value change
-
+$38,442,838
-
Number of buys
-
59
-
Number of sells
-
40
Institutional Holders of Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) as of Q4 2020
As of 31 Dec 2020 Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) had 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 22,809,127 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Sofinnova Investments, Inc., Cormorant Asset Management, LP, VANGUARD GROUP INC, Artisan Partners Limited Partnership, ALLIANCEBERNSTEIN L.P., FMR LLC, STATE STREET CORP, and GOLDMAN SACHS GROUP INC.
This table shows 115 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.